Following several years of litigation, a Benicar settlement was announced by the makers of the popular blood pressure drug on August 1, 2017, offering financial compensation for certain individuals who experienced gastrointestinal problems, such as:
Sprue-like Enteropathy (“SLE”)
“Celiac-like” Enteropathy (“CLE”)
Nausea, Vomiting and Weight Loss
Misdiagnosis of Celiac Disease
The agreement to settle Benicar cases comes following several years of litigation in the federal court system, where more than 2,000 lawsuits have been filed against Daiichi Sankyo and Forest Laboratories over the failure to adequately warn consumers and the medical community about the link between Benicar and chronic diarrhea symptoms.
Under terms of the settlement offer, the drug maker will pay $300 million in financial compensation to resolve claims involving certain injuries stemming from the use of Benicar prior to May 2015.
For individuals who have not yet filed a lawsuit over Benicar gastrointestinal problems experienced following use of the drug, there may still be limited time to pursue financial compensation. The settlement requires that any unfiled claims have a signed retainer agreement with an attorney before 11:59 pm Eastern Daylight Time on August 23, 2017.
The Benicar lawyers at the Plymale Law Firm are continuing to provide free case evaluations for individuals who suspect that they may qualify for a settlement. However, limited time remains to obtain the necessary information to pursue a case, and meet various deadlines outlined in the Benicar settlement agreement.
A court-ordered census for all filed and unfiled claims must be filed by August 25, and the deadline for the Benicar injury settlement will require eligible plaintiffs to submit an “Opt In Package”, with at least 95% of all claimants agreeing to accept the offer before the settlement will be finalized. Therefore, it is important that immediate steps be taken if you believe that you or a loved one may be eligible to settle a Benicar injury claim.